查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1881490

植入式心臟復律去顫器市場 - 全球產業規模、佔有率、趨勢、機會及預測，依產品、類型、NYHA分級、最終用戶、地區和競爭格局分類，2020-2030年預測

Implantable Cardioverter Defibrillator Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Product, By Type, By NYHA Class, By End-User, By Region, Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 184 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球植入式心臟復律去顫器（ICD）市場規模為36.2億美元，預計2030年將以6.53%的複合年成長率成長至52.9億美元。植入式心臟復律去顫器（ICD）是一種透過手術植入的醫療器械，用於持續監測心律並提供電療（例如除顫或起搏），以糾正危及生命的心律不整並預防心臟驟停。全球市場擴張的促進因素包括心血管疾病盛行率的上升、人口老化導致心臟疾病風險增加，以及技術進步提高了設備的效率和使用壽命。

市場概覽
預測期 2026-2030
2024年市場規模 36.2億美元
2030年市場規模 52.9億美元
2025-2030年複合年成長率 6.53%
成長最快的細分市場 T-ICD
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球植入式心臟復律去顫器市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品分類（經靜脈植入式心臟復律去顫器、皮下植入式心臟復律去顫器）
    • 按類型（單腔ICD、雙腔ICD、雙心室裝置）
    • 依紐約心臟協會（NYHA）分級（NYHA II級、NYHA 三級）
    • 依最終使用者（醫院、門診手術中心、其他）分類
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美植入式心臟復律去顫器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲植入式心臟復律去顫器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區植入式心臟復律去顫器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲植入式心臟復律去顫器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲植入式心臟復律去顫器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球植入式心臟復律去顫器市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Abbott Laboratories Inc.
  • Medtronic Plc
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • MicroPort Scientific Corporation
  • LivaNova PLC

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 22151

The Global Implantable Cardioverter Defibrillator Market, valued at USD 3.62 Billion in 2024, is projected to experience a CAGR of 6.53% to reach USD 5.29 Billion by 2030. An Implantable Cardioverter Defibrillator (ICD) is a medical device surgically placed to continuously monitor cardiac rhythm and deliver electrical therapy, such as defibrillation or pacing, to correct life-threatening arrhythmias and prevent sudden cardiac arrest. The global market's expansion is driven by the increasing prevalence of cardiovascular diseases, an aging population more susceptible to cardiac conditions, and technological advancements enhancing device efficiency and longevity.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 3.62 Billion
Market Size 2030USD 5.29 Billion
CAGR 2025-20306.53%
Fastest Growing SegmentT-ICDs
Largest MarketNorth America

Key Market Drivers

The increasing incidence of cardiovascular diseases and sudden cardiac arrest serves as a primary driver for the global implantable cardioverter defibrillator market. As populations age and lifestyles introduce new cardiac risk factors, the number of individuals susceptible to life-threatening arrhythmias requiring ICD therapy expands. These critical cardiac events necessitate effective interventions to prevent sudden cardiac death and improve patient outcomes.

Key Market Challenges

A primary challenging factor confronting the global implantable cardioverter defibrillator market is the considerable expenditure associated with both device implantation and subsequent long-term patient care. These substantial financial hurdles directly restrict patient access to necessary therapy, particularly within regions characterized by developing healthcare infrastructures. This limitation on accessibility translates into a slower adoption rate for implantable cardioverter defibrillators, thereby impeding the overall market expansion.

Key Market Trends

Artificial intelligence and machine learning are significantly impacting the Global Implantable Cardioverter Defibrillator Market by enhancing diagnostic precision and optimizing therapy. These technologies empower ICDs to analyze vast cardiac data for personalized treatment. The 2025 Scientific Statement from the European Heart Rhythm Association, Heart Rhythm Society, and ESC Working Group on E-Cardiology highlighted AI's potential in advanced arrhythmia detection and outcome prediction.

Key Market Players

  • Abbott Laboratories Inc.
  • Medtronic Plc
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • MicroPort Scientific Corporation
  • LivaNova PLC

Report Scope:

In this report, the Global Implantable Cardioverter Defibrillator Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Implantable Cardioverter Defibrillator Market, By Product:

  • Transvenous Implantable Cardioverter Defibrillators
  • Subcutaneous Implantable Cardioverter Defibrillators

Implantable Cardioverter Defibrillator Market, By Type:

  • Single Chamber ICDs
  • Dual Chamber ICDs
  • Biventricular Devices

Implantable Cardioverter Defibrillator Market, By NYHA Class:

  • NYHA Class II
  • NYHA Class III

Implantable Cardioverter Defibrillator Market, By End-User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Implantable Cardioverter Defibrillator Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Implantable Cardioverter Defibrillator Market.

Available Customizations:

Global Implantable Cardioverter Defibrillator Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Implantable Cardioverter Defibrillator Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Transvenous Implantable Cardioverter Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators)
    • 5.2.2. By Type (Single Chamber ICDs, Dual Chamber ICDs, Biventricular Devices)
    • 5.2.3. By NYHA Class (NYHA Class II, NYHA Class III)
    • 5.2.4. By End-User (Hospitals, Ambulatory Surgical Centers, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America Implantable Cardioverter Defibrillator Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Type
    • 6.2.3. By NYHA Class
    • 6.2.4. By End-User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Implantable Cardioverter Defibrillator Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By NYHA Class
        • 6.3.1.2.4. By End-User
    • 6.3.2. Canada Implantable Cardioverter Defibrillator Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By NYHA Class
        • 6.3.2.2.4. By End-User
    • 6.3.3. Mexico Implantable Cardioverter Defibrillator Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By NYHA Class
        • 6.3.3.2.4. By End-User

7. Europe Implantable Cardioverter Defibrillator Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Type
    • 7.2.3. By NYHA Class
    • 7.2.4. By End-User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Implantable Cardioverter Defibrillator Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By NYHA Class
        • 7.3.1.2.4. By End-User
    • 7.3.2. France Implantable Cardioverter Defibrillator Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By NYHA Class
        • 7.3.2.2.4. By End-User
    • 7.3.3. United Kingdom Implantable Cardioverter Defibrillator Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By NYHA Class
        • 7.3.3.2.4. By End-User
    • 7.3.4. Italy Implantable Cardioverter Defibrillator Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By NYHA Class
        • 7.3.4.2.4. By End-User
    • 7.3.5. Spain Implantable Cardioverter Defibrillator Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By NYHA Class
        • 7.3.5.2.4. By End-User

8. Asia Pacific Implantable Cardioverter Defibrillator Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Type
    • 8.2.3. By NYHA Class
    • 8.2.4. By End-User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Implantable Cardioverter Defibrillator Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By NYHA Class
        • 8.3.1.2.4. By End-User
    • 8.3.2. India Implantable Cardioverter Defibrillator Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By NYHA Class
        • 8.3.2.2.4. By End-User
    • 8.3.3. Japan Implantable Cardioverter Defibrillator Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By NYHA Class
        • 8.3.3.2.4. By End-User
    • 8.3.4. South Korea Implantable Cardioverter Defibrillator Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By NYHA Class
        • 8.3.4.2.4. By End-User
    • 8.3.5. Australia Implantable Cardioverter Defibrillator Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By NYHA Class
        • 8.3.5.2.4. By End-User

9. Middle East & Africa Implantable Cardioverter Defibrillator Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Type
    • 9.2.3. By NYHA Class
    • 9.2.4. By End-User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Implantable Cardioverter Defibrillator Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By NYHA Class
        • 9.3.1.2.4. By End-User
    • 9.3.2. UAE Implantable Cardioverter Defibrillator Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By NYHA Class
        • 9.3.2.2.4. By End-User
    • 9.3.3. South Africa Implantable Cardioverter Defibrillator Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By NYHA Class
        • 9.3.3.2.4. By End-User

10. South America Implantable Cardioverter Defibrillator Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Type
    • 10.2.3. By NYHA Class
    • 10.2.4. By End-User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Implantable Cardioverter Defibrillator Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By NYHA Class
        • 10.3.1.2.4. By End-User
    • 10.3.2. Colombia Implantable Cardioverter Defibrillator Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By NYHA Class
        • 10.3.2.2.4. By End-User
    • 10.3.3. Argentina Implantable Cardioverter Defibrillator Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By NYHA Class
        • 10.3.3.2.4. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Implantable Cardioverter Defibrillator Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott Laboratories Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Medtronic Plc
  • 15.3. Biotronik SE & Co. KG
  • 15.4. Boston Scientific Corporation
  • 15.5. MicroPort Scientific Corporation
  • 15.6. LivaNova PLC

16. Strategic Recommendations

17. About Us & Disclaimer